El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Vinyals, Antònia et al., 2025
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/223486

Regulatory Mechanisms of SPARC Overexpression in Melanoma Progression

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

The expression of the Secreted Protein, Acidic and Rich in Cysteine (SPARC) gene in human melanoma increases during progression and is associated with epithelial-to-mesenchymal transition (EMT), which is a major determinant of metastasis in melanoma patients. However, the underlying molecular mechanisms that control SPARC expression in this context remain elusive. Herein, we identified Paired-related homeobox 1 (PRRX1), an EMT transcription factor, as a transcriptional activator of SPARC by direct binding to the promoter, thereby increasing its activity. Moreover, we found a strong positive correlation between SPARC and PRRX1 expression levels in clinical samples and cell lines. Furthermore, the switch from the proliferative/melanocytic phenotype toward the invasive/mesenchymal-like phenotype favors the expression of TCF7L2, a beta-catenin cofactor, which, together with Sp1, binds to the proximal SPARC promoter, thereby bolstering protein expression. We also show that SPARC is a target of the miR-29 family, whose members are expressed in clinical melanoma samples and cell lines. Indeed, we found that miR-29b1 similar to a expression is inversely correlated with SPARC levels, and it is significantly reduced in samples with a mesenchymal-like phenotype. Taken together, SPARC expression in melanoma cells relies on transcriptional activation by PRRX1/TCF7L2-Sp1 and is modulated through miR-29b1 similar to a, which provides fine-tuning regulation over the switch between phenotypic states.

Matèries (anglès)

Citació

Citació

VINYALS, Antònia, FERRERES RIERA, Jose ramon, CAMPOS MARTÍN, Rafael, JORGE TORRES, Olga c., MAINEZ VILLORO, Jessica, PUIG BUTILLÉ, Joan anton, MARCOVAL CAUS, Joaquim, PUIG I SARDÀ, Susana, FABREGAT ROMERO, Isabel, FABRA FRES, Àngels. Regulatory Mechanisms of SPARC Overexpression in Melanoma Progression. _International Journal of Molecular Sciences_. 2025. Vol. 26, núm. 17, pàgs. 8743. [consulta: 3 de gener de 2026]. ISSN: 1422-0067. [Disponible a: https://hdl.handle.net/2445/223486]

Exportar metadades

JSON - METS

Compartir registre